The webinar will focus on recent developments regarding enabling disclosure requirements from antibodies to Markush groups which will impact pharma claiming in particular and chemical claiming practice in general. The webinar will look at the present, provide suggestions where the courts may end up, and how to avoid the potential pitfalls.